ANI Pharmaceuticals, Inc. (ANIP)

NGM – Real Time Price. Currency in USD

79.50

+0.79 (1.00%)

At close: May 12, 2026, 4:00 PM EDT

80.10

+0.60 (0.75%)

Pre-market: May 13, 2026, 8:11 AM EDT

11.05.2026

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

ANI Pharmaceuticals tops Q1 estimates as Cortrophin Gel sales climb 42%, prompting it to raise the 2026 revenue, EBITDA and EPS outlook.

08.05.2026

ANI Pharmaceuticals Q1 Earnings Call Highlights

ANI Pharmaceuticals NASDAQ: ANIP reported first-quarter 2026 results that management said show continued progress in its effort to “accelerat[e] our transformation into a leading rare disease company,” led by growth in Cortrophin Gel and ILUVIEN, contributions from a new intellectual property licensing transaction with Harmony Biosciences, and steady generics performance.

08.05.2026

3 Stocks Showing Powerful Earnings Acceleration This May

ANIP, CMI and SDRL stand out in May as earnings acceleration stocks, with rising EPS growth trends signaling potential share price momentum.

08.05.2026

ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript

08.05.2026

ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for ANI (ANIP) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

08.05.2026

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.7 per share a year ago.

08.05.2026

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended March 31, 2026.

Videos

No Data

There is no data to display

Press releases

08.05.2026

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

20.04.2026

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

PRINCETON, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pimozide Tablets 1 mg and 2 mg. ANI's Pimozide Tablets is the generic version of the reference listed drug (RLD) Orap®.

13.04.2026

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

PRINCETON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg and 300 mg. ANI's Carbamazepine Extended-Release Capsules are the generic version of the reference listed drug (RLD) Carbatrol®.

08.04.2026

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Isosorbide Mononitrate Tablet USP, 10 mg and 20 mg. ANI's Isosorbide Mononitrate Tablet USP is the generic version of the reference listed drug (RLD) Monoket®.

ANI Pharmaceuticals, Inc. (ANIP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ANI Pharmaceuticals, Inc. (ANIP)

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

ANI Pharmaceuticals Q1 Earnings Call Highlights

3 Stocks Showing Powerful Earnings Acceleration This May

ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript

ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

ANI Pharmaceuticals Q1 Earnings Call Highlights

3 Stocks Showing Powerful Earnings Acceleration This May

ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript

ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

Search stocks

ANI Pharmaceuticals, Inc. (ANIP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ANI Pharmaceuticals, Inc. (ANIP)

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

ANI Pharmaceuticals Q1 Earnings Call Highlights

3 Stocks Showing Powerful Earnings Acceleration This May

ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript

ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

ANI Pharmaceuticals Q1 Earnings Call Highlights

3 Stocks Showing Powerful Earnings Acceleration This May

ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript

ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet